Cytokinetics earnings estimates are expected to outperform. Discover if buying now is a smart move for investors.

Standard Chartered earnings show impressive Q3 performance, exceeding expectations in both profits and revenues.

Jio IPO Listing reveals key insights for investors. Shares debut at a significant premium, hitting Rs 1375.

Defence stock comparison reveals which company offers better growth potential.

Nifty Sensex performance shows mixed results amid bank and IT stock declines.

Jio IPO allotment status is now finalised. Discover how to check yours easily on BSE, NSE, and KFin.

ReplyAll funding news highlights a Rs 9.7 crore investment in Pre-Series A funding, showcasing startup growth.